PATH clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 113 studies whose lead sponsor is PATH. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2026.
Keep track of what changes. Save the PATH studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions PATH leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 →
- Study of a Novel Type 3 Oral Poliomyelitis Vaccine in PanamaRecruitingNCT05654467Phase 2
- Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines EvaluationRecruitingNCT06895486Phase 2
- Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADBNot yet recruitingNCT06129916
- Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis VaccinesRecruitingNCT06137664Phase 1/2
- A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra LeoneNot yet recruitingNCT06395207Not applicable
- TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse OximetersRecruitingNCT05527990
- A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and IndiaRecruitingNCT04010448Phase 3
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingNCT06879327Phase 2
- Study of a Novel Type 1 Oral Poliomyelitis Vaccine in BangladeshCompletedNCT05644184Phase 2
- Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in TunisiaCompletedNCT05621876
- Developing a Screening Tool for Primary Immunodeficiency Disease (PID) in PakistanCompletedNCT05758506
- Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaActive, not recruitingNCT06516042Phase 3
- MaCRA Part B in NigeriaWithdrawnNCT06805110Not applicable
- MaCRA Part B in Côte d'IvoireWithdrawnNCT06804902Not applicable
- Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, SenegalSuspendedNCT06225297Phase 4
- Controlled Human Infection Model Challenge/RechallengeCompletedNCT04992520Phase 1
- Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young GirlsCompletedNCT04508309Phase 3
- Study of Novel Types 1 and 3 Oral Poliomyelitis VaccinesCompletedNCT04529538Phase 1
- Proactive Community Case Management for Malaria in ZambiaCompletedNCT04839900Not applicable
- Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial TherapyCompletedNCT04661579Phase 2
- Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding AssaysCompletedNCT04666350
- Stimulating Private Sector Malaria ControlCompletedNCT01397851Not applicable
- Attractive Targeted Sugar Bait Phase III Trial in ZambiaActive, not recruitingNCT04800055Not applicable
- Feasibility and Usability of COVID-19 Antigen RDTs in UgandaCompletedNCT05630300Not applicable
- Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in UgandaCompletedNCT05462509Not applicable
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in RwandaCompletedNCT04230161
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in MozambiqueCompletedNCT04716387
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina FasoCompletedNCT04157894
- Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in MozambiqueCompletedNCT04724161
- Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina FasoCompletedNCT04545905
- Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus VaccineCompletedNCT04344054Phase 2
- A Study on Voluntary Routine COVID-19 Self-testing in Mizoram, India.Status unknownNCT05614388Not applicable
- Evaluating the Clinical Performance and Usability of Novel Malaria RDTs in BrazilStatus unknownNCT05317117Not applicable
- Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy AdultsCompletedNCT04232943Phase 1
- Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the USCompletedNCT04010695Not applicable
- Kenya: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum HemorrhageCompletedNCT04502173
- Ghana: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum HemorrhageCompletedNCT05340777
- Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy InfantsCompletedNCT03896477Phase 3
- Assessing a Risk Model for G6PD DeficiencyTerminatedNCT03337152Phase 4
- Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in BrazilCompletedNCT04033640Not applicable
- Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated BloodCompletedNCT04054661Not applicable
- Safety Study of Inactivated Shigella Whole Cell Vaccine in AdultsCompletedNCT01509846Phase 1
- Dose Escalating Study of Intramuscular Invaplex[AR-DETOX]CompletedNCT03869333Phase 1
- Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy AdultsCompletedNCT02810340Phase 1
- Cholera Anti-Secretory Treatment TrialCompletedNCT04150250Phase 2
- Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu VaccineCompletedNCT03300050Phase 1
- Safety, Acceptability, and Feasibility of Enterade®TerminatedNCT03782272Not applicable
- Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug AdministrationCompletedNCT02654912Phase 4
- Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)CompletedNCT03404674Phase 1
- Honduras Liger Thermocoagulator StudyCompletedNCT03510273Not applicable